$WGS GeneDx has seen a remarkable increase in stock value, rising 457% since April 2024 and achieving a 50-bagger return since mid-November 2023. At its lowest point, the company's market capitalization was $30 million, with $130 million in cash and annualized revenues of $200 million, alongside a gross profit of $100 million. However, the company reported a 30% decline in sales quarter-over-quarter for the period ending September 30, 2023, and has only three quarters of cash available despite a strong balance sheet, indicated by a current ratio of 3. Meanwhile, $WW International shares surged approximately 49% premarket, following a 47% increase in the prior session. The stock has experienced significant volatility, with additional trading activity leading to a further 50% rise premarket. In related news, $FTG.TO reported strong Q3 2024 results, showcasing a 29% year-over-year increase in bookings, an 18% rise in revenue, a 45% increase in EBITDA, and a 109% jump in net income, following a recent acquisition. The stock is currently viewed as an attractive investment opportunity at a valuation of only 7 times EBITDA.